-
Use, variability, and justification of eligibility criteria for phase II and III clinical trials in acute leukemia. Haematologica. 2024 Apr 01; 109(4):1046-1052. View in:
Pubmed
-
Race/ethnic associations with comprehensive cancer center access and clinical trial enrollment for acute leukemia. J Natl Cancer Inst. 2024 Mar 22. View in:
Pubmed
-
Perspectives of Oncologists on the Ethical Implications of Using Artificial Intelligence for Cancer Care. JAMA Netw Open. 2024 Mar 04; 7(3):e244077. View in:
Pubmed
-
Shifting from Equality toward Equity: Addressing Disparities in Research Participation for Clinical Cancer Research. J Clin Ethics. 2024; 35(1):8-22. View in:
Pubmed
-
Sociodemographic associations with uptake of novel therapies for acute myeloid leukemia. Blood Cancer J. 2023 12 21; 13(1):192. View in:
Pubmed
-
ASCO Ethical Guidance for the Practical Management of Oncology Drug Shortages. J Clin Oncol. 2024 Jan 20; 42(3):358-365. View in:
Pubmed
-
Digital Health to Patient-Facing Artificial Intelligence: Ethical Implications and Threats to Dignity for Patients With Cancer. JCO Oncol Pract. 2024 Mar; 20(3):314-317. View in:
Pubmed
-
Association of social deprivation with survival in younger adult patients with AML: an Alliance study. Blood Adv. 2023 08 08; 7(15):4019-4023. View in:
Pubmed
-
National Cancer Institute Centers With Environmental Sustainability Plans for Climate Change. JAMA Netw Open. 2023 06 01; 6(6):e2317206. View in:
Pubmed
-
Environmental Health: Translating Policy Into Action. Ann Intern Med. 2022 Nov; 175(11):1612-1613. View in:
Pubmed
-
Ethics Consultation in Oncology: The Search for Quality in Quantity. JCO Oncol Pract. 2022 09; 18(9):610-613. View in:
Pubmed
-
A Process Framework for Ethically Deploying Artificial Intelligence in Oncology. J Clin Oncol. 2022 12 01; 40(34):3907-3911. View in:
Pubmed
-
Inequities in Alliance Acute Leukemia Clinical Trial and Biobank Participation: Defining Targets for Intervention. J Clin Oncol. 2022 11 10; 40(32):3709-3718. View in:
Pubmed
-
Impact of Allocation on Survival During Intermittent Chemotherapy Shortages: A Modeling Analysis. J Natl Compr Canc Netw. 2022 04; 20(4):335-341.e17. View in:
Pubmed
-
Racial and ethnic enrollment disparities and demographic reporting requirements in acute leukemia clinical trials. Blood Adv. 2021 11 09; 5(21):4352-4360. View in:
Pubmed
-
Peri-transfusion quality-of-life assessment for patients with myelodysplastic syndromes. Transfusion. 2021 10; 61(10):2830-2836. View in:
Pubmed
-
Model solutions for ethical allocation during cancer medicine shortages. Lancet Haematol. 2021 04; 8(4):e246-e248. View in:
Pubmed
-
Author Correction: Fit older adults with advanced myelodysplastic syndromes: who is most likely to benefit from transplant? Leukemia. 2021 Apr; 35(4):1223. View in:
Pubmed
-
US State Government Crisis Standards of Care Guidelines: Implications for Patients With Cancer. JAMA Oncol. 2021 02 01; 7(2):199-205. View in:
Pubmed
-
Gait speed, survival, and recommended treatment intensity in older adults with blood cancer requiring treatment. Cancer. 2021 03 15; 127(6):875-883. View in:
Pubmed
-
Fit older adults with advanced myelodysplastic syndromes: who is most likely to benefit from transplant? Leukemia. 2021 04; 35(4):1166-1175. View in:
Pubmed
-
A Qualitative Analysis of Oncology Patient Awareness of Medication Shortages and Their Preferences for How Shortages Should Be Managed. JCO Oncol Pract. 2020 10; 16(10):e1098-e1111. View in:
Pubmed
-
An Action Plan for Environmentally Sustainable Cancer Care. JAMA Oncol. 2020 04 01; 6(4):469-470. View in:
Pubmed
-
A Cross-Sectional Survey of Medical Trainee Experiences During Medication Shortages. J Grad Med Educ. 2020 Feb; 12(1):38-43. View in:
Pubmed
-
Measurable residual disease monitoring for patients with acute myeloid leukemia following hematopoietic cell transplantation using error corrected hybrid capture next generation sequencing. PLoS One. 2019; 14(10):e0224097. View in:
Pubmed
-
Practical allocation system for the distribution of specialised care during cellular therapy access scarcity. J Med Ethics. 2019 08; 45(8):532-537. View in:
Pubmed
-
Prevalence and Severity of Rationing During Drug Shortages: A National Survey of Health System Pharmacists. JAMA Intern Med. 2019 05 01; 179(5):710-711. View in:
Pubmed
-
Imatinib is still recommended for frontline therapy for CML. Blood Adv. 2018 12 26; 2(24):3648-3652. View in:
Pubmed
-
Severe hemophagocytic lymphohistiocytosis in a melanoma patient treated with ipilimumab + nivolumab. J Immunother Cancer. 2018 07 16; 6(1):73. View in:
Pubmed
-
Creating Coherent Strategies to Combat the Crises of Opioid Scarcity and Abuse. J Clin Oncol. 2018 09 01; 36(25):2575-2577. View in:
Pubmed
-
Molecular Minimal Residual Disease Testing in Acute Myeloid Leukemia: A Review for the Practicing Clinician. Clin Lymphoma Myeloma Leuk. 2018 10; 18(10):636-647. View in:
Pubmed
-
A Rules-Based Algorithm to Prioritize Poor Prognosis Cancer Patients in Need of Advance Care Planning. J Palliat Med. 2018 06; 21(6):846-849. View in:
Pubmed
-
Efficacy of single-agent decitabine in relapsed and refractory acute myeloid leukemia. Leuk Lymphoma. 2017 09; 58(9):1-7. View in:
Pubmed
-
TP53 and Decitabine in Acute Myeloid Leukemia and Myelodysplastic Syndromes. N Engl J Med. 2016 11 24; 375(21):2023-2036. View in:
Pubmed
-
No Exit: Identifying Avoidable Terminal Oncology Intensive Care Unit Hospitalizations. J Oncol Pract. 2016 10; 12(10):e901-e911. View in:
Pubmed
-
Drug and vaccine access in the Ebola epidemic: advising caution in compassionate use. Ann Intern Med. 2015 Jan 20; 162(2):141-2. View in:
Pubmed
-
A new family with a germline ANKRD26 mutation and predisposition to myeloid malignancies. Leuk Lymphoma. 2014 Dec; 55(12):2945-6. View in:
Pubmed
-
A protocol and ethical framework for the distribution of rationed chemotherapy. J Clin Ethics. 2014; 25(2):102-15. View in:
Pubmed
-
Analysis of very elderly (=80 years) non-hodgkin lymphoma: impact of functional status and co-morbidities on outcome. Br J Haematol. 2012 Jan; 156(2):196-204. View in:
Pubmed
